Terns Pharmaceuticals Total Current Liabilities

Terns Pharmaceuticals (TERN) currently reports a total current liabilities of $16M as of December 2025. That compares with $16M in the prior-year period — up 4.9% year over year. Use the charts on this page to explore Terns Pharmaceuticals's total current liabilities history and peer comparisons.

Terns Pharmaceuticals's total current liabilities increased from $16M to $16M — a 4.9% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Terns Pharmaceuticals reported $16M in total current liabilities as of December 2025. That compares with $16M in the prior-year period — up 4.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Terns Pharmaceuticals, and consider following TERN for alerts when major investors trade the stock.

Terns Pharmaceuticals is classified in the Healthcare sector. On total current liabilities, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TERN with unrelated industries.